Product Description
Endothelial-Monocyte Activating Polypeptide-II (EMAP-II) is a tumor derived cytokine that is an anti-angiogenic factor in tumor Vascular development, and strongly inhibits tumor growth. Recombinant human EMAP-II is an 18.3 kDa protein containing 166 amino acid residues.
Biovision | 4463 | EMAP II human recombinant DataSheet
Biomolecule/Target: EMAP II
Synonyms: AIMP1, EMAP2, EMAP-2, EMAPII, SCYE1, Multisynthetase complex auxiliary component p43, Endothelial monocyte-activating polypeptide 2, EMAP-II, p43,
Alternates names: IFN- 1, Interferon -
Taglines: A proinflammatory cytokine chemotactic for monocytes and granulocytes
NCBI Gene ID #: 3439
NCBI Gene Symbol: IFNA1
Gene Source: Human
Accession #: NM_024013
Recombinant: Yes
Source: E. coli
Purity by SDS-PAGEs: 95%
Assay: SDS-PAGE
Purity: N/A
Assay #2: HPLC
Endotoxin Level: <0.1 ng/g
Activity (Specifications/test method): N/A
Biological activity: N/A
Results: 20-40 ng/ml
Binding Capacity: N/A
Unit Definition: N/A
Molecular Weight: 19.3 kDa
Concentration: N/A
Appearance: Lyophilized protein
Physical form description: Lyophilized from a concentrated (1 mg/ml) solution in HO containing 20 mM sodium Phosphate buffer pH7.5 and 130 mM sodium chloride.
Reconstitution Instructions: Reconstitute in HO to a concentration of 0.1-1 mg/ml. This solution can then be diluted into other aqueous buffers
Amino acid sequence: N/A